Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk
Catherine Frenette, Ari Isaacson, Irene Bargellini, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2019) Vol. 3, Iss. 3, pp. 302-310
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Management of Hepatocellular Carcinoma
Zachary J. Brown, Diamantis I. Tsilimigras, Samantha M. Ruff, et al.
JAMA Surgery (2023) Vol. 158, Iss. 4, pp. 410-410
Closed Access | Times Cited: 324
Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
Zachariah H. Foda, Akshaya V. Annapragada, Kavya Boyapati, et al.
Cancer Discovery (2022) Vol. 13, Iss. 3, pp. 616-631
Open Access | Times Cited: 98
Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
Bipul Gnyawali, Antoinette Pusateri, Ashley Nickerson, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 29, pp. 3793-3802
Open Access | Times Cited: 39
Advancements in the Diagnosis of Hepatocellular Carcinoma
Natalia Salinas Parra, Heather M. Ross, Adnan Khan, et al.
International Journal of Translational Medicine (2023) Vol. 3, Iss. 1, pp. 51-65
Open Access | Times Cited: 31
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 28
The Role of Artificial Intelligence in the Detection and Implementation of Biomarkers for Hepatocellular Carcinoma: Outlook and Opportunities
Arian Mansur, Andrea Vrionis, Jonathan Charles, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2928-2928
Open Access | Times Cited: 24
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
Reem Ezzat, Mohamed Eltabbakh, Mohamed El‐Kassas
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 12, pp. 1919-1938
Open Access | Times Cited: 47
Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Cancer Antigen 125, Prostate-Specific Antigen and Other Cancer Markers: A Primer on Commonly Used Cancer Markers
Shreya Desai, Achuta Kumar Guddati
World Journal of Oncology (2023) Vol. 14, Iss. 1, pp. 4-14
Open Access | Times Cited: 21
Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic Review and Meta-Analysis
Lalita Lumkul, Phatcharida Jantaree, Kritsada Jaisamak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1258-1258
Open Access | Times Cited: 6
Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review
Alla Turshudzhyan, George Y. Wu
Journal of Clinical and Translational Hepatology (2021) Vol. 10, Iss. 1, pp. 159-163
Open Access | Times Cited: 33
Serum biomarkers and ultrasensitive biosensors for diagnosis of early-stage hepatocellular carcinoma
Lorico DS. Lapitan, Mariusz Pietrzak, Marek Krawczyk, et al.
Sensors and Actuators B Chemical (2023) Vol. 393, pp. 134209-134209
Open Access | Times Cited: 13
Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States
Fernand Bteich, Kush Desai, Chenxin Zhang, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 257-269
Open Access | Times Cited: 5
Isolated calvarial lesion as the initial presentation of metastatic hepatocellular carcinoma: A case report and review of the literature
Jeffrey Chen, Nisha Giridharan, Arman A. Kavoussi, et al.
Surgical Neurology International (2025) Vol. 16, pp. 6-6
Closed Access
Circulating microRNAs as promising diagnostic biomarkers for hepatocellular carcinoma: a systematic review and meta-analysis
Ermiyas Alemayehu, Alebachew Fasil, Hussen Ebrahim, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 4
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 02, pp. e82-e158
Closed Access
Impact of HIV Infection on Hepatocellular Carcinoma: A Long-Term Prognostic Analysis
Yuhang Diao, Fengxia Gong, Yong Cheng
Journal of Laparoendoscopic & Advanced Surgical Techniques (2025) Vol. 35, Iss. 2, pp. 109-117
Closed Access
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
Daniel C. Bruhm, Nicholas A. Vulpescu, Zachariah H. Foda, et al.
Nature reviews. Cancer (2025)
Closed Access
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 03, pp. e159-e260
Closed Access
Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?
James J. Harding, Danny N. Khalil, Ghassan K. Abou‐Alfa
Digestive Diseases and Sciences (2019) Vol. 64, Iss. 4, pp. 918-927
Closed Access | Times Cited: 33
Cancer Screening in Refugees and Immigrants: A Global Perspective
Patricia F. Walker, Ann Settgast, Malini B. DeSilva
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 6, pp. 1593-1600
Open Access | Times Cited: 17
Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management
Jessica Elderkin, Najeeb Al Hallak, Asfar S. Azmi, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5118-5118
Open Access | Times Cited: 10
Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV
Pantong Davwar, Edith Okeke, Mary Duguru, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282539-e0282539
Open Access | Times Cited: 9
Advances in the Early Detection of Hepatobiliary Cancers
Hasan Çağrı Yıldırım, Gözde Kavgacı, Elvin Chalabiyev, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3880-3880
Open Access | Times Cited: 9
Artificial Intelligence and Complex Network Approaches Reveal Potential Gene Biomarkers for Hepatocellular Carcinoma
Antonio Lacalamita, Grazia Serino, Ester Pantaleo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15286-15286
Open Access | Times Cited: 9
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 01, pp. e67-e161
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top